Synchronous malignant tumors of the larynx with various histogenesis: leiomyosarcoma and squamous cell carcinoma—A case report Authors: Olga V. Cheremisina, Sergey V. Vtorushin, Marina V. Vusik, Denis E. Kulbakin, Sergei S. Naumov, Nadezhda V. Krakhmal Published: 2025 ABSTRACT BackgroundSquamous cell carcinoma accounts for up to 95% of malignant laryngeal tumors, whereas leiomyosarcoma is exceptionally rare, with fewer than 50 cases reported worldwide. The synchronous occurrence of two histogenetically distinct malignancies in the larynx is extremely uncommon and represents a diagnostic and therapeutic challenge.Case presentation.We describe a 66-year-old Caucasian male with synchronous laryngeal tumors: a well-differentiated squamous cell carcinoma of the right vocal fold and a high-grade leiomyosarcoma of the subglottic region. Diagnosis was established using endoscopy, histopathology, and immunohistochemistry. The patient underwent total laryngectomy with permanent tracheostomy followed by adjuvant radiotherapy. At follow-up, no recurrence or progression was detected.ConclusionThis case illustrates the rare coexistence of epithelial and mesenchymal malignancies in the larynx and emphasizes the importance of multimodal diagnostic evaluation to guide optimal surgical management. Background Epithelial tumors represent the most common neoplasms of the larynx. Laryngeal cancer (LC) accounts for approximately 1% of all malignant tumors worldwide and is the most frequent among head and neck carcinomas, comprising up to 40% of malignancies in this anatomical region. Among the histological subtypes, squamous cell carcinoma (SCC) clearly predominates, arising either from the stratified squamous epithelium of the vocal folds or from areas of metaplasia within the respiratory epithelium. SCC is reported to constitute 95–98% of all laryngeal cancers [1–5]. Mesenchymal tumors of the larynx are distinctly uncommon and are usually malignant. They include lymphomas, melanomas, and various sarcomas, which together account for less than 1% of all laryngeal neoplasms. Chondrosarcoma is the most frequently observed, while osteosarcoma, liposarcoma, and fibrosarcoma occur more rarely [2, 6, 7]. Even more unusual are isolated reports of angiosarcoma or embryonal rhabdomyosarcoma [8, 9]. Primary leiomyosarcoma of the larynx is exceptionally rare, typically arising from the tunica media of blood vessels, arrector pili muscles, or pluripotent mesenchymal cells. Fewer than 50 cases have been documented globally, usually in older adults [10–13]. The phenomenon of multiple primary malignant neoplasms (MPMNs) has received increasing attention in recent years owing to advances in diagnostics and improved survival of patients with cancer. A diagnosis of polyneoplasia is reserved for situations in which two or more tumors develop independently within the same organ, are histologically distinct, and cannot be attributed to recurrence, metastasis, or direct spread of a primary tumor [5]. Such occurrences are most frequently reported in the gastrointestinal tract, bronchopulmonary system, and skin [4]. A review of the international literature on laryngeal MPMNs identified only two reports of leiomyosarcoma developing metachronously in patients with a prior SCC of the larynx [14, 15]. To date, only six cases of synchronous SCC and leiomyosarcoma of the larynx have been described [3, 4, 16–18]. The extreme rarity of such cases underscores their clinical importance. Careful reporting of these observations is essential for improving awareness among clinicians, refining diagnostic approaches in patients with atypical or heterogeneous laryngeal lesions, and guiding optimal treatment strategies. Case presentation Patient O., a 66-year-old Caucasian male, sought consultation in November 2024 at the Department of Head and Neck Tumors, Cancer Research Institute, Tomsk National Research Medical Center, presenting with progressive hoarseness. His history revealed dysphonia for approximately 3 years. During this period, he was monitored in a local outpatient clinic, diagnosed with a “right vocal fold fibroma,” and treated conservatively. By late 2024, symptoms had worsened, prompting endoscopic excision of the lesion. Histological examination of the excised tissue revealed no malignancy, although the slides were not subjected to a second review. Subsequent indirect laryngoscopy demonstrated a nodular lesion involving the entire right vocal fold, with suspected extension into the subglottic region. Videolaryngoscopy (EVIS EXERA III, Olympus, Japan) in standard white light revealed deformation of the glottic space by a pink nodular mass occupying the right vocal fold (Fig. 1A). At the distal margin of this lesion, a second mass was visualized in the right subglottic region as a grayish-pink nodular formation with a smooth surface (Fig. 1B). Narrow-band imaging (NBI) revealed distinct vascular patterns: the vocal fold lesion displayed short, densely packed and distorted vessels with elongated, thickened irregular vessels (Fig. 1C), whereas the subglottic lesion showed thin, pinpoint distorted vessels (Fig. 1D). These marked differences in vascular architecture raised clinical suspicion of two separate neoplastic processes, leading to targeted biopsies from both regions. A summary of the clinical course is presented in Table 1.Fig. 1Endoscopic examination of the larynx (photographs): A videolaryngoscopy under white light. Tumor of the vocal folds. B Videolaryngoscopy under white light. Tumor of the subglottic space. C Narrow-band imaging (NBI) videolaryngoscopy. Tumor of the vocal folds. D Narrow-band imaging (NBI) videolaryngoscopy. Tumor of the subglottic spaceTable 1Timeline of clinical events in the present caseTimeEventFindings/actions2021Onset of dysphoniaPatient noted persistent hoarseness, followed at local outpatient clinic2021–2024Outpatient follow-upDiagnosed with “right vocal fold fibroma,” received conservative treatmentLate 2024Symptom progressionWorsening hoarseness, local treatment ineffective; endoscopic excision performed. Histology: no malignancy (slides not re-reviewed)November 2024Referral to tertiary centerIndirect laryngoscopy and videolaryngoscopy revealed two distinct lesions (vocal fold and subglottic). NBI showed different vascular patterns, raising suspicion of two neoplasmsNovember 2024Biopsies performedVocal fold: SCC G1. Subglottic: spindle cell neoplasm of uncertain malignant potential → IHC recommended12 December, 2024HospitalizationPreparation for definitive treatment18 December, 2024Total laryngectomy with permanent tracheostomySurgery uneventfulPostoperative periodPathology of resected specimenConfirmed synchronous tumors: SCC G1 (vocal fold) and leiomyosarcoma G3 (subglottic). Margins negative Endoscopic examination of the larynx (photographs): A videolaryngoscopy under white light. Tumor of the vocal folds. B Videolaryngoscopy under white light. Tumor of the subglottic space. C Narrow-band imaging (NBI) videolaryngoscopy. Tumor of the vocal folds. D Narrow-band imaging (NBI) videolaryngoscopy. Tumor of the subglottic space Table 1Timeline of clinical events in the present caseTimeEventFindings/actions2021Onset of dysphoniaPatient noted persistent hoarseness, followed at local outpatient clinic2021–2024Outpatient follow-upDiagnosed with “right vocal fold fibroma,” received conservative treatmentLate 2024Symptom progressionWorsening hoarseness, local treatment ineffective; endoscopic excision performed. Histology: no malignancy (slides not re-reviewed)November 2024Referral to tertiary centerIndirect laryngoscopy and videolaryngoscopy revealed two distinct lesions (vocal fold and subglottic). NBI showed different vascular patterns, raising suspicion of two neoplasmsNovember 2024Biopsies performedVocal fold: SCC G1. Subglottic: spindle cell neoplasm of uncertain malignant potential → IHC recommended12 December, 2024HospitalizationPreparation for definitive treatment18 December, 2024Total laryngectomy with permanent tracheostomySurgery uneventfulPostoperative periodPathology of resected specimenConfirmed synchronous tumors: SCC G1 (vocal fold) and leiomyosarcoma G3 (subglottic). Margins negative Timeline of clinical events in the present case Microscopic examination of the vocal fold biopsy demonstrated an invasive epithelial neoplasm composed of epithelioid cells with squamous differentiation. Tumor nests and clusters of varying size contained cells with abundant eosinophilic cytoplasm, round to oval nuclei with normochromatic to hyperchromatic features, fine chromatin, and distinct nucleoli. Nuclear pleomorphism was mild. Intracellular keratinization foci and a desmoplastic stroma with moderate edema and lymphoid infiltration were observed. Diagnosis: well-differentiated squamous cell carcinoma (G1) of the larynx (ICD-O 8070/3). The subglottic biopsies revealed a spindle cell neoplasm composed of pleomorphic cells with oval to angular nuclei arranged in disorganized fascicles. At this stage, the tumor was classified as a spindle cell neoplasm of uncertain malignant potential, and immunohistochemical (IHC) analysis was recommended. The patient was hospitalized on 12 December, 2024, and underwent total laryngectomy with permanent tracheostomy on 18 December, 2024. The postoperative period was uneventful. Histological and IHC examination of the surgical specimen confirmed the coexistence of two topographically distinct malignant tumors. The right vocal fold lesion was a well-differentiated SCC consistent with the biopsy findings (Fig. 2), measuring 0.6 cm in thickness, without cartilage invasion, perineural infiltration, or vascular invasion.Fig. 2Squamous cell carcinoma with keratinization. The tumor consists of nests of varying size with invasive growth and signs of keratinization. Hematoxylin and eosin staining; × 200 Squamous cell carcinoma with keratinization. The tumor consists of nests of varying size with invasive growth and signs of keratinization. Hematoxylin and eosin staining; × 200 The subglottic tumor exhibited multinodular growth with central coagulative necrosis and extension into adjacent soft tissues (Fig. 3). Morphology showed spindle cell architecture with marked nuclear pleomorphism, numerous mitotic figures ( > 20 per 10 high-power fields, including atypical mitoses), and areas of necrosis (Figs. 4, 5). Surgical margins were free of tumor.Fig. 3Overview scan of the histological section of the subglottic laryngeal tumor. The tumor infiltrates the organ wall and extends into the surrounding soft tissues. An eosinophilic area of coagulative necrosis is observed in the central part of the tumor nodule. Whole-slide image obtained using Aperio AT2 scanner. Hematoxylin and eosin stainingFig. 4Laryngeal leiomyosarcoma. The tumor is composed of fascicles of spindle-shaped cells with nuclear pleomorphism; mitotic figures are present. Hematoxylin and eosin staining; × 200Fig. 5Laryngeal leiomyosarcoma. Marked nuclear pleomorphism; nucleoli are visible in many cells. Numerous mitotic figures are identified. Hematoxylin and eosin staining; × 400 Overview scan of the histological section of the subglottic laryngeal tumor. The tumor infiltrates the organ wall and extends into the surrounding soft tissues. An eosinophilic area of coagulative necrosis is observed in the central part of the tumor nodule. Whole-slide image obtained using Aperio AT2 scanner. Hematoxylin and eosin staining Laryngeal leiomyosarcoma. The tumor is composed of fascicles of spindle-shaped cells with nuclear pleomorphism; mitotic figures are present. Hematoxylin and eosin staining; × 200 Laryngeal leiomyosarcoma. Marked nuclear pleomorphism; nucleoli are visible in many cells. Numerous mitotic figures are identified. Hematoxylin and eosin staining; × 400 Immunohistochemistry (IHC; Leica Bond Max) was performed using antibodies to SMA, Desmin, S-100, and Caldesmon. The tumor showed strong cytoplasmic expression of SMA (clone asm-1, Leica) and was negative for Desmin (clone DE-R-11, Leica), S-100 (Dako), and Caldesmon (clone H-CD, Dako) (Figs. 6, 7, 8).Fig. 6Laryngeal leiomyosarcoma. Diffuse staining of tumor cells with smooth muscle actin (SMA) antibody. Immunohistochemistry; × 200Fig. 7Laryngeal leiomyosarcoma. Focal staining of tumor cells with Desmin antibody. Immunohistochemistry; × 400Fig. 8Laryngeal leiomyosarcoma. Diffuse staining of tumor cells with Caldesmon antibody. Immunohistochemistry; × 200 Laryngeal leiomyosarcoma. Diffuse staining of tumor cells with smooth muscle actin (SMA) antibody. Immunohistochemistry; × 200 Laryngeal leiomyosarcoma. Focal staining of tumor cells with Desmin antibody. Immunohistochemistry; × 400 Laryngeal leiomyosarcoma. Diffuse staining of tumor cells with Caldesmon antibody. Immunohistochemistry; × 200 Final diagnosis: well-differentiated squamous cell carcinoma of the larynx, G1, pT2N0M0, stage II (C32.0) High-grade leiomyosarcoma of the larynx, G3, pT1bN0M0, stage II (C49.0). Based on these findings, the patient was referred for adjuvant external beam radiotherapy. A full course of 50 Gy was delivered to the laryngeal bed and regional lymphatic drainage zones. The treatment was well tolerated. At 6 month follow-up, no recurrence or progression was detected. Discussion The incidence of MPMNs has increased in recent years, largely owing to the overall rise in cancer incidence, advances in diagnostic imaging and endoscopic techniques, and improved survival after radical oncological treatment. These factors have collectively contributed to the higher detection of synchronous and metachronous tumors [19, 20]. In the present case, two histologically distinct malignant tumors of the larynx were identified simultaneously, fulfilling the criteria for synchronous neoplasms. In most published series, multiple primary laryngeal tumors consist exclusively of SCCs of different grades of differentiation. The reported incidence of synchronous SCCs ranges from 1% to 10%, while metachronous tumors account for 10–20% of cases. They are most frequently observed in male smokers, especially when the primary lesion involves the supraglottic region [20, 21]. In contrast, the synchronous coexistence of SCC with a malignant tumor of mesenchymal origin in the larynx is extremely rare. Only isolated case reports describe such combinations, including one report of concurrent laryngeal chondrosarcoma and in situ SCC affecting both vocal cords [22]. The uniqueness of the present case lies in the synchronous presence of two topographically separate and histogenetically distinct malignant tumors: a well-differentiated SCC of the right vocal fold and a high-grade leiomyosarcoma of the subglottic region. Leiomyosarcoma of the larynx is exceptionally uncommon, with fewer than 50 cases reported worldwide. Unlike SCC, its development has no established association with smoking or alcohol consumption. Instead, several hereditary and acquired conditions have been implicated in its pathogenesis, including Gardner, Werner, and Turcot syndromes, nevoid basal cell carcinoma syndrome, tuberous sclerosis, neurofibromatosis, retinoblastoma, and prior radiation exposure [16]. Because of the extreme rarity of synchronous SCC and leiomyosarcoma, there are no standardized diagnostic or therapeutic guidelines. Treatment strategies described in the literature are highly individualized, depending on tumor location, extent, and institutional expertise. In our case, the combination of endoscopic findings, histopathology, and immunohistochemistry (IHC) was essential for accurate diagnosis. The chosen management—total laryngectomy followed by adjuvant radiotherapy—proved oncologically sound, with no recurrence detected during follow-up. Limitations This case report has inherent limitations. As with all single-case observations, causal relationships cannot be established, and generalizability is limited. Furthermore, diagnostic uncertainty existed preoperatively, as the suspicion of two distinct neoplasms was initially based only on differences in vascular architecture on narrow-band imaging, which carries the risk of interpretative bias. In addition, the relatively short follow-up period (6 months) limits the strength of the conclusions, as longer monitoring would be required to confirm the absence of recurrence or metastasis. Nevertheless, the case highlights the value of multimodal endoscopic and histopathological assessment in complex presentations. Contemporary relevance Recent studies have reinforced the importance of long-term vigilance in patients with laryngeal SCC, who remain at elevated risk of second primary malignancies. A SEER-based analysis demonstrated a significantly increased risk of second cancers in laryngeal cancer survivors, particularly in the lungs and upper aerodigestive tract [23]. A Finnish population-based study found that this risk persists even more than 20 years after the initial diagnosis [24]. Additional cohort data confirm that secondary tumors represent a frequent cause of late morbidity in this patient group [25]. These findings underscore the necessity of thorough diagnostic evaluation in patients with atypical or multifocal laryngeal lesions and justify continued long-term follow-up after initial treatment. Our case adds to this evidence by documenting the rare synchronous occurrence of two histogenetically distinct tumors within the larynx. Conclusion This case illustrates the extremely rare coexistence of squamous cell carcinoma and leiomyosarcoma in the larynx. It highlights the need for a high index of suspicion when endoscopic and morphological features appear heterogeneous and underscores the critical role of multimodal diagnostics, particularly immunohistochemistry, in guiding appropriate management.